In summary, this study demonstrates that HIF-1α transgenic BMCs possess better capabilities of osteogenesis and angiogenesis in vitro, and can increase vascularization and bone regeneration in the early-stage osteonecrosis of femoral head in the rabbit model. This evidence concerns the gene HIF1A and osteonecrosis.